Fresenius Kabi Oncology continues to crash as promoters’ intent to delist the MNC

01 Jun 2012 Evaluate

As the equity markets continue their downward trajectory, the Indian companies’ foreign promoters are anxious to exit. The pharmaceutical MNC - Fresenius Kabi Oncology, is the first prey to this mayhem as its promoters, in a letter to the company dated May 30, 2012, have proposed to delists it from the stock exchanges. This news has crashed the stock by nearly 30%.

Fresenius Kabi Oncology is currently trading at Rs. 96.50, down by 11.60 points or 10.73% from its previous closing of Rs. 108.10 on the BSE.

The scrip opened at Rs. 91.55 and has touched a high and low of Rs. 98.90 and Rs. 87.15 respectively. So far 838244 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 176.00 on 17-Apr-2012 and a 52 week low of Rs. 81.65 on 20-Dec-2011.

Last one week high and low of the scrip stood at Rs. 145.40 and Rs. 108.10 respectively. The current market cap of the company is Rs. 1473.89 crore.

The promoters holding in the company stood at 90.00% while Institutions and Non-Institutions held 2.45% and 7.55% respectively.

Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×